Related Experiment Video
Updated: Jun 8, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner
Yoseph Addadi1, Neta Moskovits, Dorit Granot
1Department of Biological Regulation, The Weizmann Institute, Rehovot, Israel.
Abstract:
The p53 tumor suppressor exerts a variety of cell-autonomous effects that are aimed to thwart tumor development. In addition, however, there is growing evidence for cell nonautonomous tumor suppressor effects of p53. In the present study, we investigated the impact of stromal p53 on tumor growth. Specifically, we found that ablation of p53 in fibroblasts enabled them to promote more efficiently the growth of tumors initiated by PC3 prostate cancer-derived cells. This stimulatory effect was dependent on the increased expression of the chemokine SDF-1 in the p53-deficient fibroblasts. Notably, fibroblasts harboring mutant p53 protein were more effective than p53-null fibroblasts in promoting tumor growth. The presence of either p53-null or p53-mutant fibroblasts led also to a markedly elevated rate of metastatic spread of the PC3 tumors. These findings implicate p53 in a cell nonautonomous tumor suppressor role within stromal fibroblasts, through suppressing the production of tumor stimulatory factors by these cells. Moreover, expression of mutant p53 by tumor stroma fibroblasts might exert a gain of function effect, further accelerating tumor development.
Insights
The p53 tumor suppressor protein (p53) normally inhibits tumor growth. Loss of p53 in surrounding stromal cells enhances prostate cancer growth and metastasis, suggesting a novel tumor suppressor role for p53.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The p53 tumor suppressor protein (p53) is crucial for preventing tumor development through cell-autonomous functions.
- Emerging evidence suggests p53 also plays a role in cell nonautonomous tumor suppression.
Purpose of the Study:
- To investigate the impact of stromal p53 on tumor growth and metastasis.
- To elucidate the mechanisms by which stromal p53 influences tumor progression.
Main Methods:
- Utilized PC3 prostate cancer cells and genetically modified fibroblasts with varying p53 statuses (p53-null, p53-mutant).
- Assessed tumor growth and metastatic spread in a preclinical model.
- Quantified chemokine expression, specifically SDF-1, in fibroblasts.
Main Results:
- Ablation of p53 in fibroblasts significantly promoted PC3 tumor growth.
- This promotion was linked to increased expression of the chemokine SDF-1 in p53-deficient fibroblasts.
- Fibroblasts expressing mutant p53 were more effective at promoting tumor growth than p53-null fibroblasts.
- Loss or mutation of p53 in stromal fibroblasts markedly increased tumor metastasis.
Conclusions:
- p53 acts as a cell nonautonomous tumor suppressor in stromal fibroblasts by inhibiting the production of tumor-promoting factors like SDF-1.
- Mutant p53 in stromal fibroblasts may confer a gain-of-function advantage, accelerating tumor development and metastasis.
More Related Videos
07:20A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
Published on: February 28, 2020
11:31Isolation of Normal and Cancer-associated Fibroblasts from Fresh Tissues by Fluorescence Activated Cell Sorting (FACS)
Published on: January 14, 2013
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules